News
CuraTeQ Biologics s.r.o., announced that the CHMP of the European Medicines Agency has adopted a positive opinion recommending marketing authorisation of Dazublys®, its trastuzumab biosimilar, for the ...
So if you’ve somehow missed this one, or you’ve been putting it off for something lighter, now’s the time. It’s one of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback